Stock Market

PDS Biotechnology Reports GAAP EPS Loss of $0.74

By Bullbit Editorial · March 30, 2026

• WhatPDS Biotechnology reports GAAP EPS loss
• WhyLoss attributed to operational expenses
• SignalCompany's financial struggles persist
• TargetInvestors await future revenue growth
• RiskHigh operational costs remain a concern

More breaking news →